Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics-Reference-Cited by-同舟云学术

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

Published:2007-06 Issue:6 Volume:137 Page:530-536
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shaughnessy John D.,Haessler Jeffrey,van Rhee Frits,Anaissie Elias,Pineda-Roman Mauricio,Cottler-Fox Michele,Hollmig Klaus,Zangari Maurizio,Mohiuddin Abid,Alsayed Yazan,Grazziutti Monica,Epstein Joshua,Crowley John,Barlogie Bart

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2007.06586.x/fullpdf

Reference20 articles.

1. High Serum Levels of Lactic Dehydrogenase Identify a High-Grade Lymphoma-like Myeloma

2. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma

3. Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies

4. Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

5. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients;Journal of Clinical Laboratory Analysis;2024-09-12

2. Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens;Frontiers in Oncology;2022-09-14

3. Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real‐world analysis;Journal of Clinical Laboratory Analysis;2022-03-30

4. The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides;Leukemia & Lymphoma;2020-06-10

5. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?;Cancer Genetics;2020-04